Oxford Immunotec to Participate in Two Investor Conferences This Week
November 26 2018 - 5:31PM
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth
diagnostics company, today announced that Dr. Peter Wrighton-Smith,
Chief Executive Officer, is scheduled to present at the following
investor conferences this week.
- Evercore ISI HealthCONx Conference on Tuesday, November 27,
2018 at 2:45 p.m. ET. The conference will be held at the Boston
Harbor Hotel in Boston.
- 30th Annual Piper Jaffray Healthcare Conference on Wednesday,
November 28, 2018 at 2:00 p.m. ET. The conference will be held at
the Lotte New York Palace in New York City.
A live audio webcast of the fireside chat at the
Piper Jaffray Conference on Wednesday, November 28 will be
available online from the investor relations page of the Company's
corporate website at www.oxfordimmunotec.com. A webcast replay will
be available approximately 24 hours after the live presentation and
will be archived on the website for approximately 90 days.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global,
high-growth diagnostics company focused on developing and
commercializing proprietary assays for immunology and infectious
disease. The Company's T-SPOT®.TB test has been approved for sale
in over 50 countries, including the United States, where it has
received pre-market approval from the Food and Drug Administration,
Europe, where it has obtained a CE mark, as well as Japan and
China. The Company is headquartered near Oxford, U.K. and in
Marlborough, MA. Additional information can be found at
www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks
of Oxford Immunotec Ltd.
CONTACTS:
For Media and Investor
Inquiries:Karen KoskiVP, Strategy and Investor
RelationsOxford ImmunotecTel: +1 (508)
556-1377kkoski@oxfordimmunotec.com
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Apr 2023 to Apr 2024